| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 20610 |
|
2,471 |
532 |
$12K |
| 77002 |
|
2,508 |
649 |
$6K |
| 76881 |
|
715 |
153 |
$4K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
580 |
70 |
$3K |
| 73580 |
|
903 |
184 |
$1K |
| 27370 |
|
414 |
153 |
$558.94 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
85 |
41 |
$384.50 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
700 |
115 |
$378.00 |
| 76882 |
|
103 |
41 |
$316.42 |
| 27369 |
|
46 |
13 |
$274.69 |
| 73560 |
|
137 |
37 |
$60.58 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
853 |
290 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
175 |
67 |
$0.00 |
| G9500 |
Radiation exposure indices documented in final report for procedure using fluoroscopy |
614 |
208 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
27 |
13 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
861 |
292 |
$0.00 |
| 4040F |
|
139 |
53 |
$0.00 |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
25 |
13 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
724 |
251 |
$0.00 |
| 1006F |
|
783 |
281 |
$0.00 |
| G9908 |
Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
20 |
12 |
$0.00 |
| 1101F |
|
129 |
52 |
$0.00 |